Your browser doesn't support javascript.
loading
Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol.
Nishii, Kazuya; Inoue, Masaaki; Obata, Hideto; Ueda, Yutaka; Kozuki, Toshiyuki; Yamasaki, Masahiro; Moritaka, Tomonori; Awaya, Yoshikazu; Sugimoto, Keisuke; Gemba, Kenichi; Kuyama, Shoichi; Ichikawa, Hirohisa; Shibayama, Takuo; Kubota, Tetsuya; Kodani, Masahiro; Kishino, Daizo; Fujimoto, Nobukazu; Ishikawa, Nobuhisa; Tsubata, Yukari; Ishii, Tomoya; Fujitaka, Kazunori; Hotta, Katsuyuki; Kiura, Katsuyuki.
Afiliação
  • Nishii K; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Inoue M; Shimonoseki City Hospital, Shimonoseki, Japan.
  • Obata H; Yamaguchi-ken Saiseikai Shimonoseki General Hospital, Shimonoseki, Japan.
  • Ueda Y; Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Kozuki T; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Yamasaki M; Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Moritaka T; Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Awaya Y; Miyoshi Central Hospital, Miyoshi, Japan.
  • Sugimoto K; Japanese Red Cross Kobe Hospital, Kobe, Japan.
  • Gemba K; Chugoku Central Hospital, Fukuyama, Japan.
  • Kuyama S; National Hospital Organization Iwakuni Clinical Center, Iwakuni, Japan.
  • Ichikawa H; KKR Takamatsu Hospital, Takamatsu, Japan.
  • Shibayama T; National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Kubota T; Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Nankoku, Japan.
  • Kodani M; Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Kishino D; Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Fujimoto N; Okayama Rosai Hospital, Okayama, Japan.
  • Ishikawa N; Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Tsubata Y; Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
  • Ishii T; Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Miki, Japan.
  • Fujitaka K; Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Hotta K; Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Kiura K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Thorac Cancer ; 12(5): 725-731, 2021 03.
Article em En | MEDLINE | ID: mdl-33434415
ABSTRACT

INTRODUCTION:

Conventional cancer registries are suitable for simple surveillance of cancer patients, including disease frequency and distribution, demographics, and prognosis; however, the collected data are inadequate to clarify comprehensively diverse clinical questions in daily practice.

METHODS:

We constructed an umbrella-type lung cancer patient registry (CS-Lung-003) integrating multiple related prospective observational studies (linked studies) that reflect clinical questions about lung cancer treatment. The primary endpoint of this registry is to clarify daily clinical practice patterns in lung cancer treatment; a key inclusion criterion is pathologically diagnosed lung cancer. Under this registry, indispensable clinical items are detected in advance across all active linked studies and gathered prospectively and systematically to avoid excessive or insufficient data collection. Researchers are to input information mutually, irrespective of the relevance to each researcher's own study. Linked studies under the umbrella of the CS-Lung-003 registry will be updated annually with newly raised clinical questions; some linked studies will be newly created, while others will be deleted after the completion of the analysis. Enrollment began in July 2017.

DISCUSSION:

We successfully launched the umbrella-type CS-Lung-003 registry. Under this single registry, researchers collaborate on patient registration and data provision for their own and other studies. Thus, the registry will produce results for multiple domains of study, providing answers to questions about lung cancer treatment raised by other researchers. Through such analysis of each linked study, this registry will contribute to the comprehensive elucidation of actual daily practice patterns in lung cancer treatment. KEY POINTS CS-Lung-003 registry directly integrates multiple linked studies created under the umbrella of this cancer registry to solve various clinical questions regarding daily practice patterns of lung cancer treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article